Diabetic muscle infarction: A new perspective on pathogenesis and management

Two patients with insulin dependent diabetes mellitus developed recurrent episodes of focal muscle pain and swelling. Clinical evaluation, magnetic resonance imaging (MRI) and muscle biopsy confirmed the diagnosis of recurrent hemorrhagic muscle infarctions. Our studies suggest that muscle infarction occurred because of hypercoagulability and associated vascular endothelial damage. Based on these findings we recommend long-term anticoagulation to prevent recurrent infarction.

[1]  J. V. van Wersch,et al.  Coagulation activation in diabetes mellitus. , 1990, Haemostasis.

[2]  J. Davies.  The pre-thrombotic state. , 1985, Clinical science.

[3]  R. Becker.  Seminars in Thrombosis, Thrombolysis and Vascular Biology , 1991 .

[4]  I. Ford,et al.  Activation of Coagulation in Diabetes Mellitus in Relation to the Presence of Vascular Complications , 1991, Diabetic medicine : a journal of the British Diabetic Association.

[5]  A. Barnett,et al.  Platelet Aggregation and Coagulation Factors in Insulin Dependent Diabetics With and Without Microangiopathy , 1987, Diabetic medicine : a journal of the British Diabetic Association.

[6]  E. Salzman.  Progress in Hemostasis and Thrombosis , 1981 .

[7]  M. Hultin,et al.  Factor VII activity state in coronary artery disease. , 1988, The Journal of laboratory and clinical medicine.

[8]  S. Thompson,et al.  HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY , 1986, The Lancet.

[9]  B. Banker,et al.  Focal Infarction of Muscle in Diabetics , 1986, Diabetes Care.

[10]  W. Lawson,et al.  Elevation of factor VII activity and mass in young adults at risk of ischemic heart disease. , 1989, Journal of the American College of Cardiology.

[11]  G. Mariani,et al.  Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus. , 1992, Thrombosis research.

[12]  B. Banker,et al.  Infarction of thigh muscle in the diabetic patient , 1973, Neurology.

[13]  E. Bierman.  Atherogenesis in diabetes , 1992 .

[14]  G. Assmann,et al.  Epidemiological Study on Factor VII, Factor VIII and Fibrinogen in an Industrial Population - II. Baseline Data on the Relation to Blood Pressure, Blood Glucose, Uric Acid, and Lipid Fractions , 1985, Thrombosis and Haemostasis.

[15]  S. Ringel,et al.  Distribution of capillaries in normal and diseased human skeletal muscle , 1986, Muscle & nerve.

[16]  Hultin Mb.  Fibrinogen and factor VII as risk factors in vascular disease. , 1991 .

[17]  A. Bloom.  Physiology of blood coagulation. , 1990, Haemostasis.

[18]  H. Keen,et al.  Haemostatic variables associated with diabetes and its complications. , 1979, British medical journal.

[19]  H. Roberts,et al.  New perspectives on the coagulation cascade. , 1992, Hospital Practice.

[20]  M. Alessi,et al.  Deficient t-PA Release and Elevated PA Inhibitor Levels in Patients with Spontaneous or Recurrent Deep Venous Thrombosis , 1987, Thrombosis and Haemostasis.

[21]  J. Kissel,et al.  Case‐of‐the‐month: Painful thigh mass in a young woman: Diabetic muscle infarction , 1992, Muscle & nerve.

[22]  P. Maccallum,et al.  Reduction of factor VII coagulant activity (VIIC), a risk factor for ischaemic heart disease, by fixed dose warfarin: a double blind crossover study. , 1990, British heart journal.

[23]  J. Harrelson,et al.  Microangiopathic Ischemic Myopathy of Semimembranosus Muscle in Patient With Diabetes Mellitus , 1992, Diabetes Care.

[24]  K. Ucar,et al.  Hypercoagulability and thrombosis. , 1992, Hematology/oncology clinics of North America.

[25]  S. Gough,et al.  The Fibrinolytic System in Diabetes Mellitus , 1991, Diabetic medicine : a journal of the British Diabetic Association.

[26]  H. Niwano,et al.  Circulating thrombomodulin as a novel endothelial cell marker: Comparison of its behavior with von willebrand factor and tissue‐type plasminogen activator , 1992, American journal of hematology.

[27]  Y. Nemerson.  Tissue factor and hemostasis. , 1988, Blood.

[28]  P. Brennan,et al.  Randomized controlled trial of low dose warfarin in the primary prevention of ischaemic heart disease in men at high risk: design and pilot study. , 1988, European heart journal.

[29]  E. Bierman.  George Lyman Duff Memorial Lecture. Atherogenesis in diabetes. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[30]  H. Kwaan.  Changes in Blood Coagulation, Platelet Function, and Plasminogen-Plasmin System in Diabetes , 1992, Diabetes.

[31]  Y. Nemerson,et al.  Evidence for the presence of tissue factor activity on subendothelium. , 1989, Blood.

[32]  J. Matthews,et al.  Infarction of the quadriceps muscle: a complication of diabetic vasculopathy. , 1986, Southern medical journal.

[33]  H. Gerlach,et al.  Endothelium and Regulation of Coagulation , 1991, Diabetes Care.

[34]  P. Winocour.  Platelet Abnormalities in Diabetes Mellitus , 1992, Diabetes.